EVALUASI POTENSI INTERAKSI OBAT ANTIDIABETIKA ORAL DI APOTEK PERINTIS KURIPAN BANJARMASIN
DOI:
https://doi.org/10.36387/jifi.v4i2.821Keywords:
Antidiabetics, Potential interactions, Mechanism of action, severity.Abstract
Diabetes mellitus is one of the third highest chronic diseases in the world after hypertension. Diabetes mellitus is the highest disease in the Pioneer Pharmacy Kuripan Banjarmasin. The potential for interaction occurs when a patient takes two or more drugs at the same time with the effect of the interaction being beneficial or harmful or even harmful. This study aims to evaluate the potential interactions of oral antidiabetic drugs for the period January - December 2020.
This type of research is non-experimental with retrospective data collection. The number of population according to the inclusion and exclusion criteria was 784 prescription sheets from 1,015 prescription sheets. Samples were calculated using the lameshow formula and proportional random sampling technique. The instrument used is an observation sheet. The data were analyzed using the online Medscape drug interaction checker 2021 literature and the Drug Interaction Fact 2010 literature.
The results showed that the number of drug combinations with potential interactions based on the mechanism of action was 149 (39.52%) and based on pharmacodynamics 74 (48.05%), pharmacokinetics 33 (21.43%), and 47 or 30.52 unknowns. %. Meanwhile, based on severity, serious 1 (0.65%), moderate 121 (78.57%), minor 32 (20.78%).
References
2. Riskesdas. 2018. Riset Kesehatan Dasar (Riskesdas) Tahun 2018. Laporan Riskesdas Nasional 2018.
3. Suherman, S.K. 2007. Insulin dan Antidiabetik Oral. Dalam: Farmakologi dan Terapi. Departemen Farmakologi dan Terapeutik FKUI. Jakarta. Halaman 481- 493.
4. Katzung, G.B. 2002. Farmakologi Dasar dan Klinik, Edisi 8. Salemba Medika. Jakarta. Halaman 672.
5. Setiawati, A. 2007. Interaksi Obat. Dalam: Farmakologi dan Terapi. Departemen Farmakologi dan Terapeutik FKUI. Jakarta. Halaman 862- 867.
6. Rambadhe, S., A. Chakarborty, A. Shrivastava, U.K.Patil. A survey on polypharmacy and use of inappropriate medications. Toxicol Int. 2012 ;19(1):68–73. doi:10.4103/09716580.94506(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC333 9249/
7. Fulton MM, Allen ER. 2005. Polypharmacy in the elderly: A literature review. The Journal of the American Association of Nurse Practitioners. 17(4):123–32.
8. Honore, P. Hartvig. 2014. Drug Interactions. European Journal of Hospital Pharmacy. 21(2), (https://ejhp.bmj.com)
9. Laila Febgriantie., Ani Rosita., Dan A. D. 2017. Global Health Science , Volume 2 Issue 4 , Desember 2017 Issn 2503-5088 Global Health Science , Volume 2 Issue 4 .
10. Indriani, L., & Oktaviani, E. 2020. Kajian Interaksi Obat Antihipertensi Pada Pasien Rawat Inap Di Salah Satu Rumah Sakit Di Bogor, Indonesia. Majalah Farmasetika., 4(Suppl 1), 212–219. Https://Doi.Org/10.24198/Mfarmasetika.V4i0.25884
11. Agustina, R., Annisa, N., & Prabowo, W. C. 2015. Potensi Interaksi Obat Resep Pasien Hipertensi Di Salah Satu Rumah Sakit Pemerintah Di Kota Samarinda. Jurnal Sains Dan Kesehatan, 1(4), 208–213. Https://Doi.Org/10.25026/Jsk.V1i4.41
12. Villela, Lucia Maria Aversa. 2019. Pedoman Pelayanan Kefarmasian Pada Hipertensi. Journal Of Chemical Information And Modeling, 53(9), 1689–1699.
13. Hendera, & Rahayu, S. 2018. Interaksi Antar Obat Pada Peresepan Pasien Rawat Inap Pediatrik Rumah Sakit X Dengan Menggunakan Aplikasi Medscape. Journal of Current Pharmaceutical Sciences, 1(2), 75–80
